Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05919043 · ClinicalTrials.gov registry record · NA

Upper Limb-based Movement Priming for Lower Limb Neuroplasticity & Motor Recovery in Stroke

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT05919043 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05919043, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The goal of this clinical trial is to to determine the effect of movement-based priming using the upper limbs on lower limb neuroplasticity and behaviors in chronic stroke. The main questions we aim to answer are: 1. What are the acute effect of UL-priming on lower limb neuroplasticity and motor behaviors in persons with stroke compared to other priming modalities? 2. What are the time effects of UL-priming on neuroplasticity and motor behavior in individuals with stroke? In this cross over study, participants will be involved in three priming sessions involving \- UL-priming using rhythmic, symmetric, bilateral priming involving the movement of at least one major joint in the upper limbs. AND \- Sham priming using auditory stimulation (1 Hz metronome). AND \- Lower-limb movement-based priming using rhythmic, symmetric, dorsiflexion and plantarflexion movements. Researchers will compare outcome measures between the different priming sessions.

Interventions

  • OTHER Upper limb-based movement priming (UL-priming)
  • OTHER Lower limb-based movement priming (LL-priming)
  • OTHER Sham priming

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2024-07-01
Est. Completion 2025-06-25
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT05919043

The ClinicalTrials.gov registry entry for NCT05919043 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Upper limb-based movement priming (UL-priming) is the first listed.

NCT05919043 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05919043 about?

NCT05919043 is a clinical study titled "Upper Limb-based Movement Priming for Lower Limb Neuroplasticity & Motor Recovery in Stroke". The goal of this clinical trial is to to determine the effect of movement-based priming using the upper limbs on lower limb neuroplasticity and behaviors in chronic stroke. The main questions we aim to answer are: 1. What are the acute effect of UL-priming on lower limb neuroplasticity and motor b...

What is the current status of trial NCT05919043?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2024-07-01. Estimated completion is 2025-06-25.

What interventions are being tested in trial NCT05919043?

The interventions under investigation include: Upper limb-based movement priming (UL-priming) (OTHER), Lower limb-based movement priming (LL-priming) (OTHER), Sham priming (OTHER).

Who is sponsoring clinical trial NCT05919043?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.